NEOGEN CORP Logo

NEOGEN CORP

Develops, manufactures, and markets solutions for food and animal safety.

NEOG | US

Overview

Corporate Details

ISIN(s):
US6404911066
LEI:
Country:
United States of America
Address:
620 LESHER PLACE, 48912 LANSING

Description

Neogen Corporation develops, manufactures, and markets a comprehensive portfolio of solutions dedicated to food and animal safety. The company provides a diverse suite of products and services for the food, beverage, animal, and agriculture industries. Its Food Safety division offers a wide range of diagnostic test kits and systems to detect pathogens, allergens, mycotoxins, and other contaminants. The Animal Safety division provides solutions for livestock and companion animals, including genomics services for genetic analysis, as well as instruments, equipment, cleaners, and disinfectants. Neogen also delivers advanced testing solutions to specialty markets such as healthcare, public health, and laboratory testing, supporting professionals with reliable tools for analysis and research.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-04-07 18:36
8-K
English 947.7 KB
2025-04-07 17:51 English 8.1 KB
2025-02-14 22:16 English 9.1 KB
2025-02-12 15:26 English 8.3 KB
2025-01-21 15:46
PRIMARY DOCUMENT
English 7.1 KB
2025-01-16 21:28
PRIMARY DOCUMENT
English 6.5 KB
2025-01-16 18:05
PRIMARY DOCUMENT
English 6.4 KB
2025-01-15 21:53
10-Q
English 3.2 MB
2025-01-10 22:03
NT 10-Q
English 15.1 KB
2025-01-10 13:00
8-K
English 145.2 KB
2025-01-07 22:03
8-K
English 69.9 KB
2024-12-17 22:01
8-K/A
English 62.8 KB
2024-12-04 13:59
8-K
English 8.5 MB
2024-12-02 18:10
PRIMARY DOCUMENT
English 7.1 KB
2024-11-14 22:28
SCHEDULE 13G
English 20.8 KB

Automate Your Workflow. Get a real-time feed of all NEOGEN CORP filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NEOGEN CORP

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NEOGEN CORP via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Acurx Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing a new class of antibiotics for priority pathogens.
United States of America
ACXP
Adaptimmune Therapeutics PLC Logo
Commercial-stage biopharma developing TCR T-cell therapies for solid tumors.
United States of America
ADAP
ADBIOTECH Co.,Ltd. Logo
Develops IgY-based immune antibodies as alternatives to vaccines and antibiotics.
South Korea
179530
ADC Therapeutics SA Logo
Commercial-stage biotech developing antibody-drug conjugates for cancer therapy.
United States of America
ADCT
Addex Therapeutics Ltd. Logo
Clinical-stage biopharma developing allosteric modulators for neurological disorders.
Switzerland
ADXN
ADIAL PHARMACEUTICALS, INC. Logo
A clinical-stage biopharma developing genetically targeted therapies for addiction.
United States of America
ADIL
Adicet Bio, Inc. Logo
Develops allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
United States of America
ACET
Adlai Nortye Ltd. Logo
A clinical-stage biopharma firm developing cancer immunotherapies and RAS-targeting drugs.
United States of America
ANL
ADMA BIOLOGICS, INC. Logo
Biopharmaceutical company that develops and manufactures plasma-derived biologics.
United States of America
ADMA
Adverum Biotechnologies, Inc. Logo
A clinical-stage company developing gene therapies for ocular diseases.
United States of America
ADVM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.